- Home
- RVPH vs WVVI Comparison
RVPH vs WVVI Comparison
Compare RVPH & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- WVVI
- Stock Information
- Founded
- RVPH 2006
- WVVI 1983
- Country
- RVPH United States
- WVVI United States
- Employees
- RVPH N/A
- WVVI N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- RVPH Health Care
- WVVI Consumer Staples
- Exchange
- RVPH Nasdaq
- WVVI Nasdaq
- Market Cap
- RVPH 36.7M
- WVVI 29.5M
- IPO Year
- RVPH N/A
- WVVI N/A
- Fundamental
- Price
- RVPH $0.70
- WVVI $5.60
- Analyst Decision
- RVPH Strong Buy
- WVVI
- Analyst Count
- RVPH 5
- WVVI 0
- Target Price
- RVPH $9.00
- WVVI N/A
- AVG Volume (30 Days)
- RVPH 662.3K
- WVVI 12.3K
- Earning Date
- RVPH 08-13-2025
- WVVI 08-12-2025
- Dividend Yield
- RVPH N/A
- WVVI N/A
- EPS Growth
- RVPH N/A
- WVVI N/A
- EPS
- RVPH N/A
- WVVI N/A
- Revenue
- RVPH N/A
- WVVI $38,520,945.00
- Revenue This Year
- RVPH N/A
- WVVI N/A
- Revenue Next Year
- RVPH N/A
- WVVI N/A
- P/E Ratio
- RVPH N/A
- WVVI N/A
- Revenue Growth
- RVPH N/A
- WVVI N/A
- 52 Week Low
- RVPH $0.49
- WVVI $3.17
- 52 Week High
- RVPH $4.28
- WVVI $7.18
- Technical
- Relative Strength Index (RSI)
- RVPH 39.46
- WVVI 45.18
- Support Level
- RVPH $0.67
- WVVI $5.51
- Resistance Level
- RVPH $0.90
- WVVI $5.83
- Average True Range (ATR)
- RVPH 0.06
- WVVI 0.14
- MACD
- RVPH -0.02
- WVVI -0.02
- Stochastic Oscillator
- RVPH 11.36
- WVVI 48.52
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.